Lymphotoxin-Beta Receptor Blockade Reduces CXCL13 in Lacrimal Glands and Improves Corneal Integrity in the NOD Model of Sjögren's Syndrome
Arthritis Research and Therapy - United Kingdom
doi 10.1186/ar3507
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2011
Authors
Publisher
Springer Science and Business Media LLC